Viewing

Surgery

Latest News


CME Content


April 15 marked the 10-year anniversary of FDA approval of onabotulinumtoxinA (Botox Cosmetic, Allergan) to help improve the look of moderate to severe frown lines between the eyebrows in patients aged 18 to 65 years.

Numerous small-incision approaches make it possible to gain access to orbital tumors. The choice of surgical approach or combination of approaches is dictated by the size and location of the lesion or the area being pursued.